This brand name is authorized in Nigeria.
The drug MIC-ORAL contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
451W47IQ8X - SODIUM CHLORIDE
|
|
Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue. |
|
2
|
UNII
660YQ98I10 - POTASSIUM CHLORIDE
|
|
Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism. |
|
3
|
UNII
5SL0G7R0OK - ANHYDROUS DEXTROSE
|
|
Glucose is frequently used in both adults and children to restore blood glucose concentrations in the treatment of hypoglycaemia resulting from insulin excess or from other causes. The metabolism of glucose is an energy source for the body. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-2034 | Granules for solution | MIC-ORAL SACHETS GRAN_F_SOL 2.6g; 1.4g; 13.5g 1X5'S | 113 RNW-PP-264029 MIC-ORAL SACHETS GLUCOSE 13.5G, SODIUM CHLORIDE 2.6G, POTASSIUM CHLORIDE 1.5G Each sachet contains GLUCOSE 13.5G, SODIUM CHLORIDE 2.6G, POTASSIUM CHLORIDE 1.5G B4-2034 Drugs Imported Products 1X5'S Over The Counter (OTC) 10/31/2022 MICPON PHARMACY LIMITED, UPPER KUTA ROAD SAIKO MINNA NIGER 0 micponpharmacy1@gmail.com JIANGXI XIER KANGTAI PHARMACEUTICAL CO. LTD , NORTH ZONE, HIGH-NEW TECHNOLOGY INDUSTRIAL ZONE, PINGXIANG. JIANGXI, CHINA, China | 30/11/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A07CA | Oral rehydration salt formulations | A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07C Electrolytes with carbohydrates |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-2034 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.